PENTAMICE

Serial Number 88615812
Registration 6456427
700

Registration Progress

Application Filed
Sep 13, 2019
Under Examination
Nov 10, 2020
Approved for Publication
Sep 15, 2020
Published for Opposition
Sep 15, 2020
Registered
Aug 17, 2021

Basic Information

Serial Number
88615812
Registration Number
6456427
Filing Date
September 13, 2019
Registration Date
August 17, 2021
Published for Opposition
September 15, 2020
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 17, 2021
Registration
Registered
Classes
031 042

Rights Holder

CURIA IP HOLDINGS, LLC

16
Address
26 CORPORATE CIRCLE
ALBANY, NY 12203

Ownership History

LAKEPHARMA, INC.

Original Applicant
03
Belmont, CA

LAKEPHARMA, INC.

Owner at Publication
03
Irving, TX

LAKEPHARMA, INC.

Original Registrant
03
Irving, TX

CURIA IP HOLDINGS, LLC

New Owner After Registration #1
16
ALBANY, NY

Legal Representation

Attorney
Paul J. Kennedy

USPTO Deadlines

Next Deadline
769 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-08-17)
Due Date
August 17, 2027
Grace Period Ends
February 17, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

37 events
Date Code Type Description
Mar 19, 2025 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Apr 8, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 8, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 8, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 8, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 8, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 30, 2022 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 17, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER
Jul 16, 2021 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 16, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 16, 2021 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 15, 2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 14, 2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
May 24, 2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE
May 20, 2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
May 10, 2021 IUAF S USE AMENDMENT FILED
May 10, 2021 EISU I TEAS STATEMENT OF USE RECEIVED
Dec 18, 2020 DOCK D ASSIGNED TO EXAMINER
Nov 10, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 15, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 15, 2020 PUBO A PUBLISHED FOR OPPOSITION
Aug 26, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 6, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 4, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 4, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 4, 2020 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 14, 2020 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 14, 2020 GNFR O FINAL REFUSAL E-MAILED
Jul 14, 2020 CNFR R FINAL REFUSAL WRITTEN
Jun 23, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 22, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 22, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 20, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 20, 2019 GNRT F NON-FINAL ACTION E-MAILED
Dec 20, 2019 CNRT R NON-FINAL ACTION WRITTEN
Dec 14, 2019 DOCK D ASSIGNED TO EXAMINER
Sep 22, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Detailed Classifications

Class 031
Live animals for use in scientific, medical, pharmaceutical, agricultural, or industrial research
First Use Anywhere: Nov 18, 2020
First Use in Commerce: Nov 18, 2020
Class 042
Antibody drug development services, namely, research and development services in the field of antibodies
First Use Anywhere: Nov 11, 2019
First Use in Commerce: Nov 11, 2019

Classification

International Classes
031 042